Select Medical
SEM was delisted on the 30th of June, 2026.
Fund managers haven’t disclosed any holdings of SEM yet.
SEM Hedge Fund Activity: Q2 2026 in Review
238 of the 8,246 institutional investors tracked by Wall St. Rank reported a position in Select Medical (SEM) for Q2 2026, worth a combined $1.46B — down 8.3% from $1.6B a quarter earlier.
Sellers outnumbered buyers: 76 funds closed out of SEM and 44 opened new positions — a net loss of 32 holders — while 84 trimmed existing stakes and 63 added.
The largest buyer was Verition Fund Management, opening a new position worth an estimated $198M. The largest seller was Vanguard Portfolio Management, cutting an estimated $111M.
- 238 institutional investors held Select Medical (SEM) as of Q2 2026, down from 278 in Q1 2026.
- Funds reported $1.46B of Select Medical stock for Q2 2026, down 8.3% quarter-over-quarter.
- 44 funds opened new Select Medical positions in Q2 2026 and 76 closed out, a net change of -32 holders.
- The largest Select Medical buyer in Q2 2026 was Verition Fund Management, an estimated $198M added.
- The largest Select Medical seller in Q2 2026 was Vanguard Portfolio Management, an estimated $111M sold.
Based on aggregated 13F filings for Q2 2026.